James B. Breitmeyer, M.D., Ph.D.
Board Member
Vaxart, Inc. (VXRT)Equibles does not estimate personal net worth.
Get an email with a short summary when Vaxart, Inc. publishes a filing, an earnings call transcript or a press release.
Get VXRT alertsAbout James B. Breitmeyer, M.D., Ph.D.
James B. Breitmeyer, M.D., Ph.D. is recorded as Board Member at Vaxart, Inc. (VXRT) since April 23, 2026. Vaxart, Inc. reported in an 8-K filed April 23, 2026 that James B. Breitmeyer, M.D., Ph.D. was appointed member of the Board, effective April 23, 2026. Vaxart, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vaxart, Inc. includes Andrei Floroiu (CEO), Michael Finney (CEO), Michael J. Finney (CEO and Board Member) and 7 others.
“On April 23, 2026, following a recommendation by the Nominating and Governance Committee of the Board of Directors (the “Board”) of Vaxart, Inc. (the “Company”), the Board appointed James B. Breitmeyer, M.D., Ph.D. to serve on the Board, effective immediately, and until Dr. Breitmeyer’s successor is elected and qualified, or sooner in the event of his death, resignation, or removal.”
Affiliation history
-
Current
2026-04-23–present
Company network
Leadership on record at Vaxart, Inc.
- Andrei Floroiu CEO
- Michael Finney CEO
- Michael J. Finney CEO, Board Member
- Steven Lo CEO, Board Member
- Fuad Ahmad CFO
- Phillip E. Lee CFO, Chief Accounting Officer
- Edward Berg General Counsel
- Jeroen Grasman Chief Accounting Officer
- David Wheadon Board Member
- David Wheadon, M.D. Board Member